當(dāng)前位置: 首頁 - 產(chǎn)品目錄 - 小分子抑制劑
Gemcitabine, Hydrochloride Salt 鹽酸吉西他濱
貨號 | ISY1006 | 售價(元) | 548 |
規(guī)格 | 5mg | CAS號 | 122111-03-9 |
- 產(chǎn)品簡介
- 相關(guān)產(chǎn)品
貨號
名稱
規(guī)格
價格
ISY1006-0005MG
Gemcitabine, Hydrochloride Salt
5mg
548
ISY1006-0025MG
Gemcitabine, Hydrochloride Salt
25mg
1028
ISY1006-0050MG
Gemcitabine, Hydrochloride Salt
50mg
1950
ISY1006-0100MG
Gemcitabine, Hydrochloride Salt
100mg
3518
產(chǎn)品簡介:
鹽酸吉西他濱是一種DNA合成抑制劑,其IC50值為240.4±29.0微米(CCRF-CEM/dCK/細胞)、14.7±2.8納米(TC-1細胞)、36.7±5.1微米(TC-1-GR細胞)和50納米(PANC1細胞)[1]。 DNA合成是DNA分子的自然或人工創(chuàng)造,可以定義為DNA復(fù)制、聚合酶鏈?zhǔn)椒磻?yīng)和基因合成。據(jù)報道,DNA合成過程在多種癌癥中起著重要作用,許多藥物已被制成針對這一過程來抑制腫瘤生長或轉(zhuǎn)移[2] [3]。
鹽酸吉西他濱是一種DNA合成抑制劑。當(dāng)用胰腺癌細胞系COLO 357和L3.6pl進行測試時,繼染料木黃酮(其使細胞對鹽酸吉西他濱敏感)之后的鹽酸吉西他濱治療顯著抑制了細胞生長并增加了細胞凋亡[4]。在MIA PaCa-2細胞中,鹽酸吉西他濱通過抑制dDNA的活性對細胞表現(xiàn)出顯著的細胞毒性,IC50值為49.7±17.7nM[1]。 在原位植入COLO 357細胞的SCID小鼠中,與對照組相比,經(jīng)染料木黃酮和吉西他濱治療的小鼠顯著降低(75%,P < 0.01)腫瘤生長和體重[4]。
產(chǎn)品性質(zhì):
Cas No.:122111-03-9
別名:鹽酸吉西他濱; LY 188011 hydrochloride
化學(xué)名: 4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one;hydrochloride
Canonical SMILES:C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F
分子式:C9H11F2N3O4.HCI
分子量:299.66
溶解度:≥ 7.49mg/mL in Water; 25 mg/mL in DMSO (ultrasonic and warming and heat to 60°C)
儲存條件:4°C, protect from light
注意事項:
為了您的安全和健康,請穿實驗服并戴一次性手套操作。
References:
[1].Lansakara, P.D., B.L. Rodriguez, and Z. Cui, Synthesis and in vitro evaluation of novel lipophilic monophosphorylated gemcitabine derivatives and their nanoparticles. Int J Pharm, 2012. 429(1-2): p. 123-34.
[2].Kostyrev, O.A. and T.A. Leont'eva, [Autoradiographic study of DNA systhesis in muscle and connective tissue cells of the heart during exposure to isopropylnorepinephrine]. Biull Eksp Biol Med, 1973. 76(7): p. 108-11.
[3].Mathews, L.A., et al., Increased expression of DNA repair genes in invasive human pancreatic cancer cells. Pancreas, 2011. 40(5): p. 730-9.
[4].Banerjee, S., et al., Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer. Cancer Res, 2005. 65(19): p. 9064-72.